Search the Newsreel

UBS Group Boosts Elanco Animal Health (NYSE:ELAN) Price Target to $33.00

Elanco Animal Health (ELAN) Stock Eyes Margin Momentum As Debt Questions Linger

Elanco Animal Health's stock rose 2.4% following its Q2 2026 report, which showed significant improvement in adjusted EBITDA and gross margin, despite trailing losses. The company's "Big 6" portfolio and new products like Zenrelia and Credelio Quattro are driving revenue growth and market penetration. …

Phibro Animal Health (PAHC) HR chief sells 265 shares to cover tax withholding

Lisa Ann Escudero, SVP of Human Resources at Phibro Animal Health (PAHC), sold 265 shares of Class A Common Stock on August 4, 2026, to cover tax withholding obligations associated with the vesting of restricted stock units. The transaction was a broker-assisted cashless sale …

Elanco Animal Health posts Q2 2026 revenue $1.37B, raises full‑year guidance and improves net leverage

Elanco Animal Health reported strong second-quarter 2026 results, achieving $1.368 billion in revenue, a 10% year-over-year increase, and raising its full-year guidance for revenue, adjusted EBITDA, and adjusted EPS. The company also improved its year-end net leverage target and saw significant contributions from products …

Elanco Earnings: Continued Strength in Key New Products Supports Strong Quarter

Elanco Animal Health Inc (ELAN) (Q2 2026) Earnings Call Highlights: Strong Innovation Drives 8% ...

This article first appeared on GuruFocus. Revenue: $1.368 billion, up 10% reported; organic constant currency revenue grew 8%. Organic Growth Drivers: 6% increase in volume and 2% contribution from price. Pet Health Revenue (Organic CC): Total grew 11%; US up 11%, International up 9%. …

Elanco Animal Health (NYSE:ELAN) Hits New 1-Year High Following Strong Earnings

Elanco Animal Health (NYSE:ELAN) shares reached a new 52-week high after reporting strong quarterly earnings of $0.34 EPS, surpassing estimates, with revenue rising 10.2% to $1.37 billion. The company provided Q3 and full-year 2026 EPS guidance, and analysts maintain a "Moderate Buy" rating with …

Press Release: Elanco Animal Health Reports Second Quarter 2026 Results

Elanco Animal Health (ELAN) has reported its second-quarter 2026 results. The article also briefly mentions Unity Software (U.US) which reported fourth-quarter revenue of $609 million, exceeding estimates, despite a quarterly loss of 66 cents per share. Full details of the Elanco report are behind …

Elanco Animal Health (ELAN) Reports Q2 Earnings: What Key Metrics Have to Say

Elanco Animal Health Incorporated (ELAN) reported $1.37 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 10.2%. EPS of $0.34 for the same period compares to $0.26 a year ago. The reported revenue compares to the Zacks Consensus Estimate …

Reeder Teknoloji Sanayi ve Ticaret A.S. İşlem Fikirleri — BIST:REEDR

(ELAN) Elanco Animal Health Expects 2026 Revenue Range $5.09B - $5.14B, vs. FactSet Est of $5.07B

Elanco Animal Health (ELAN) announced its revenue expectations for 2026, forecasting a range of $5.09 billion to $5.14 billion. This projection surpasses the current FactSet estimate of $5.07 billion. The company also reported Q2 adjusted earnings and revenue increases, leading to an updated 2026 …

(ELAN) Elanco Animal Health Incorporated Expects Q3 Revenue Range $1.20B - $1.22B

Elanco Animal Health Incorporated (ELAN) announced its Q3 revenue expectations, projecting a range of $1.20 billion to $1.22 billion. This follows their Q2 adjusted earnings and revenue rise, which led to an increase in their 2026 outlook, with revenue expected between $5.09 billion and …

Elanco Q2 2026 earnings: Innovation demand lifts revenue and margins

Elanco Animal Health reported strong Q2 2026 earnings, with revenue up 10% to $1.368 billion and GAAP EPS rising significantly due to demand for innovative pet health products and global ruminant portfolio growth. The company raised its full-year guidance for revenue, adjusted EBITDA, and …

Elanco’s (NYSE:ELAN) Q2 CY2026: Strong Sales, Stock Soars

Elanco (NYSE: ELAN) reported stronger-than-expected Q2 CY2026 results, with revenue of $1.37 billion, a 10.2% year-on-year increase, and non-GAAP EPS of $0.34, significantly beating analyst estimates. The animal health company also raised its full-year revenue and adjusted EPS guidance, indicating positive momentum in the …

Elanco raises 2026 outlook after Q2 revenue climbs 10%

Elanco Animal Health (ELAN) reported strong Q2 2026 results with revenue up 10% year over year to $1.368 billion, and net income rising significantly. Following this performance, the company has raised its full-year 2026 financial outlook, including revenue and adjusted EPS guidance, and increased …

Elanco beats top-line and bottom-line estimates; raises FY26 outlook

* Elanco press release [https://seekingalpha.com/pr/20607348-elanco-animal-health-reports-second-quarter-2026-results] (ELAN [https://seekingalpha.com/symbol/ELAN]): Q2 Non-GAAP EPS of $0.34 beats by $0.07. * Revenue of $1.37B (+10.5% Y/Y) beats by $60M. * Adjusted EBITDA of $288 million; Adjusted EBITDA Margin of 21.2% * Full Year 2026 Guidance: * Raising innovation revenue …

Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Beat Estimates

Elanco Animal Health (ELAN) reported strong Q2 2026 earnings, beating analyst estimates for both EPS and revenue. The company posted earnings of $0.34 per share against an estimate of $0.27, and revenues of $1.37 billion, surpassing the $1.24 billion expectation. Despite this positive performance, …

Elanco Animal Health Incorporated 2026 Q2 - Results - Earnings Call Presentation (NYSE:ELAN) 2026-08-05

Elanco Animal Health reported strong second-quarter 2026 results, exceeding prior guidance with revenue up 10% to $1.368 billion, driven by new pet-health products like Zenrelia and Credelio Quattro, and growth in U.S. farm animal operations. The company raised its full-year organic constant-currency revenue growth …

PHIBRO ANIMAL HEALTH CORP SEC Filing (Aug 4, 2026)

This article details a Form 144 SEC filing by Phibro Animal Health Corp (PAHC) on August 4, 2026. The filing indicates a proposed sale of 486 shares of Class A common stock by an individual, acquired through restricted stock vesting. The aggregate market value …

Is Phibro Animal Health (PAHC) Undervalued On Its Dividend Update?

MiniMed Group Inc (NASDAQ:MMED) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Analysts have given MiniMed Group Inc (NASDAQ:MMED) a "Moderate Buy" consensus recommendation, with 13 buy ratings, two holds, and one sell from 16 firms. The average 12-month price target is $21.62, higher than the stock's opening price of $18.05. Despite mixed recent analyst actions …

First Trust Advisors LP Cuts Holdings in Elanco Animal Health Incorporated $ELAN

First Trust Advisors LP significantly reduced its stake in Elanco Animal Health Incorporated by 78.1% in the first quarter, selling 827,946 shares. Despite this, other institutional investors like PNC Financial Services Group Inc., KBC Group NV, and Swiss National Bank increased their holdings. Elanco …

Price to earnings forward of Yesodot Eitanim Construction Ltd. – TASE:YESD

REEDER TEKNOLOJI - KAP Haberleri - 2026-08-03 tarihli

Why (YPF) Price Action Is Critical for Tactical Trading

This article from Stock Traders Daily discusses why YPF's price action is critical for tactical trading, highlighting strong sentiment across all horizons and an exceptional 39.9:1 risk-reward setup. It outlines three distinct AI-generated trading strategies (Position, Momentum Breakout, and Risk Hedging) with specific entry, …

Elanco Animal Health Incorporated $ELAN Shares Bought by Defilade Capital Management L.P.

Defilade Capital Management L.P. significantly increased its stake in Elanco Animal Health Incorporated (NYSE:ELAN) by 132.0% in the first quarter, now owning over 931,000 shares valued at $22.28 million. Other institutional investors also adjusted their positions, and insider activity shows CEO Jeffrey N. Simmons …

Elanco Releases 2025 Impact Report, Demonstrating How Animal Health Helps Meet Society's Growing Needs

Elanco Animal Health Inc. has released its "2025 Impact Report," detailing how the company's focus on innovation and purpose addresses societal challenges related to animal health

Elanco (ELAN) Is Up 5.9% After Credelio Quattro Outperforms Rivals in Tick Protection Study

SONM|Sonim Technologies Inc|Price:3.392|Chg%:+0.110

This article provides an in-depth analysis of Sonim Technologies Inc. (SONM) stock, including its current market trends, real-time quotes, and trading strategies. It highlights the company's relatively stable fundamentals, significant growth potential, and high institutional ownership, despite a recent weak stock market performance. The …

108,600 Shares in YPF Sociedad Anónima $YPF Acquired by Oaktree Fund Advisors LLC

Oaktree Fund Advisors LLC has acquired 108,600 shares of YPF Sociedad Anónima (NYSE:YPF) valued at approximately $5.0 million, making it their fifth-largest holding. Other institutional investors have also increased their positions in the company, with insiders purchasing an additional 11,792 shares. Despite mixed analyst …

Arrowstreet Capital Limited Partnership Acquires 641,448 Shares of Elanco Animal Health Incorporated $ELAN

Arrowstreet Capital Limited Partnership significantly increased its stake in Elanco Animal Health Incorporated (NYSE:ELAN) by 310.0% in the first quarter, purchasing an additional 641,448 shares and bringing its total holdings to 848,372 shares valued at approximately $20.3 million. This move is part of broader …

Nimble Holdings' (HKG:186) Solid Earnings May Rest On Weak Foundations

Animalcare Group (ANCR) Delists from AIM Following Completion of Charterhouse-Backed Acquisition

Millennium group (NASDAQ: PAHC) discloses 1.06M-share Phibro Animal Health position

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have reported beneficial ownership of 1,064,608 shares of Phibro Animal Health Corporation (PAHC) Class A common stock, which represents 5.1% of the class. They indicate shared voting and dispositive power over these shares, …

YPF’s 18% Quarter Leads Integrated Oil Peers, While 0.6x Volume Keeps the Breakout Case Unfinished

YPF closed at $51.40 after a 13.4% four-week advance, but negative activity pressure and light turnover leave confirmation short of the price move.

Jeronimo Martins SGPS SA (JRONY) (H1 2026) Earnings Call Highlights: Strong Sales Growth Amid ...

This article first appeared on GuruFocus. Revenue: Group sales increased 5.1% (4.5% at constant exchange rates) to EUR18.3 billion. EBITDA: Increased 7.6% to EUR1.2 billion, with a margin of 6.8%, up 16 basis points year-over-year. Net Cash Position (ex-IFRS 16): EUR11 million as of …